Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis... see more

TSX:EDT - Post Discussion

Spectral Medical Inc > Don’t ignore the Bashers…
View:
Post by Gorf79 on Jul 18, 2022 10:34am

Don’t ignore the Bashers…

... you need to know who you are competing with for shares in Spectral.

Don't ignore your adversaries...
Comment by JohnnyCashMoney on Jul 18, 2022 10:48am
Exactly!!! You are counting on $50-$60 depending on who knows what. I'll sell you 155,000for $2.60: per share(fyi act now) you would be STUPID not too...... you have been known to be stupid 
Comment by JohnnyCashMoney on Jul 18, 2022 11:13am
The waiting is the hardest part
Comment by JohnnyCashMoney on Jul 18, 2022 11:30am
I have zero idea what your end game is, but your next screen game should be Fork Face Astonishing
Comment by goldyhawk on Jul 18, 2022 3:48pm
The wait is  reminiscent of BIOMS  Posters then were off the wall for the year before I've learned to hit the ignore button on e extremists such as GOOF and MERCEDESMAN Without them there is a much better content 
Comment by mercedesman on Jul 18, 2022 4:05pm
gawdy  - please ignore away. I will continue to anticipate all your information packed, value added posts.  I'm sorry you'll miss my upcoming factual posts as it relates to ongoing PMX studies. Did you know... JL Vincent and Ronco feel strongly that RCT for an elusive & complex affliction like Sepsis should not have a 28-day mortality endpoint, given homogenous populations ...more  
Comment by Gorf79 on Jul 18, 2022 4:13pm
Spectral isn't "on the verge of proving their case" , they have already proven it. They received the very, very, very rare "Breakthrough Designation" from the FDA.  MM I can't find anyone anywhere that received a BTD and didn't land an approval, in our case it will be very shortly thereafter.  
Comment by mercedesman on Jul 18, 2022 4:34pm
Not quite Gorf, but still encouraging ! Half Of US FDA’s Breakthrough Therapy Designations Have Resulted In Approval :: Pink Sheet (informa.com) Half of the clinical programs awarded breakthrough therapy designations have gone on to receive FDA approval, making the BTD one of the most successful of the FDA’s expedited review pathways, according to an analysis of the Pink Sheet’s US FDA ...more  
Comment by Gorf79 on Jul 18, 2022 4:36pm
Read my post below. Read it in the context of Baxter co sponsoring the approval application... Its a No Brainer MM...
Comment by mercedesman on Jul 18, 2022 4:58pm
Don't get me wrong Gorf, I place the probablity of success at MUCH higher than 50%... ...mainly because, as you say, they pretty much tick (as you point out) all the boxes of BTD ...but also becasue Baxter is involved, and ... ...also because under Tigris,  they are "greatly exceeding expectations", and also  ...because ther have been more than 200,000 safe uses , and ...more  
Comment by Gorf79 on Jul 18, 2022 6:44pm
Yes, everything you list plus they are COMMERCIAL NOW! That is correct, their SAMI product is on its way in to the largest dialysis provider in the South Eastern US in ARC dialysis. That too! The NPV on that deal alone dwarfs their current market cap. Wrap your head around that, and that is just 1 deal from division number 2!!!  Just 1 of many to come...
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities